Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-18 12:17 pm Purchase |
2025-03-06 | 13G | BioAtla, Inc. BCAB |
OPOKA INVESTMENT FUND Co | 3,547,787 6.100% |
3,547,787 (New Position) |
Filing History |
| 2025-02-10 5:04 pm Purchase |
2024-12-31 | 13G | BioAtla, Inc. BCAB |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7,349,205 9.900% |
7,349,205 (New Position) |
Filing History |
| 2025-02-07 4:41 pm Purchase |
2024-12-31 | 13G | BioAtla, Inc. BCAB |
SHORT JAY M PHD | 3,865,646 6.600% |
407,456 (+11.78%) |
Filing History |
| 2025-01-24 4:00 pm Sale |
2024-12-31 | 13G | BioAtla, Inc. BCAB |
MILLENNIUM MANAGEMENT LLC | 1,095,606 1.900% |
-1,319,209 (-54.63%) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | BioAtla, Inc. BCAB |
TANG CAPITAL MANAGEMENT LLC | 874,076 1.800% |
874,076 (New Position) |
Filing History |
| 2024-10-02 4:30 pm Sale |
2024-10-01 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 1,237,909 2.560% |
-1,410,563 (-53.26%) |
Filing History |
| 2024-09-06 4:59 pm Sale |
2024-08-19 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,648,472 5.500% |
-1,252,842 (-32.11%) |
Filing History |
| 2024-08-07 4:26 pm Purchase |
2024-08-05 | 13G | BioAtla, Inc. BCAB |
MILLENNIUM MANAGEMENT LLC | 2,414,815 5.000% |
2,414,815 (New Position) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | BioAtla, Inc. BCAB |
BLACKROCK INC BLK |
791,560 1.600% |
-2,092,454 (-72.55%) |
Filing History |
| 2024-04-16 09:15 am Sale |
2024-04-05 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 3,901,314 8.100% |
-319,083 (-7.56%) |
Filing History |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | BioAtla, Inc. BCAB |
TANG CAPITAL PARTNERS LP | 2,524,076 5.300% |
-600,000 (-19.21%) |
Filing History |
| 2024-02-09 4:58 pm Purchase |
2023-12-31 | 13G | BioAtla, Inc. BCAB |
SHORT JAY M PHD | 3,458,190 7.200% |
476,154 (+15.97%) |
Filing History |
| 2024-02-06 3:57 pm Purchase |
2023-12-31 | 13G | BioAtla, Inc. BCAB |
ACORN BIOVENTURES, L.P. | 4,032,046 8.400% |
1,305,591 (+47.89%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | BioAtla, Inc. BCAB |
BLACKROCK INC BLK |
2,884,014 6.000% |
2,884,014 (New Position) |
Filing History |
| 2023-04-27 12:11 pm Purchase |
2023-04-20 | 13G | BioAtla, Inc. BCAB |
ACORN BIOVENTURES, L.P. | 2,726,455 5.700% |
2,726,455 (New Position) |
Filing History |
| 2023-02-27 4:14 pm Purchase |
2022-12-31 | 13G | BioAtla, Inc. BCAB |
SHORT JAY M PHD | 2,982,036 6.400% |
280,709 (+10.39%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | BioAtla, Inc. BCAB |
TANG CAPITAL PARTNERS LP | 3,124,076 8.600% |
835,176 (+36.49%) |
Filing History |
| 2023-02-14 3:10 pm Purchase |
2022-12-31 | 13G | BioAtla, Inc. BCAB |
Cormorant Asset Management LP | 3,680,365 7.980% |
1,642,150 (+80.57%) |
Filing History |
| 2023-02-09 11:12 am Sale |
2022-12-30 | 13G | BioAtla, Inc. BCAB |
The Vanguard Group | 1,931,039 4.190% |
-333,615 (-14.73%) |
Filing History |
| 2023-02-06 2:49 pm Sale |
2022-12-30 | 13G | BioAtla, Inc. BCAB |
WELLINGTON MANAGEMENT CO LLP | 1,102 0.000% |
-3,231,378 (-99.97%) |
Filing History |